Cabozantinib in advanced renal cell carcinoma: A phase II, open‐label, single‐arm study of Japanese patients
暂无分享,去创建一个
M. Oya | Y. Tomita | K. Tatsugami | N. Masumori | H. Kanayama | M. Nozawa | N. Nakaigawa | Y. Miyoshi | T. Osawa | K. Nishimura | S. Tamada | N. Sassa | Akiko Kimura | S. Kuroda | Chihiro Nakayama Kondoh | Shingo Tanaka